OBJECTIVE to prepare the tolterodine osmotic pump tablet and study its release profiles in vitro.
目的制备酒石酸托特罗定渗透泵片，考察其体外释药特性。
2
Objective To prepare Tolterodine Tartrate Pills (TTP), study the character of its dissolubility, and the influence of the base on appearance, characteristics and dissolubility.
目的制备酒石酸托特罗定滴丸，考察其体外溶出特性及基质对滴丸外观性状和溶出度的影响。
3
Conclusions Solifenacin vesicare is a safer and more effective drug over tolterodine for the treatment of patients with OAB, and it could be served as a drug of first choice for treating OAB.